Asset Management One Co., Ltd. Bei Gene, Ltd. Transaction History

Asset Management One Co., Ltd.

$27.7 Billion
Q3 2024

A detailed history of Asset Management One Co., Ltd. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 20,453 shares of BGNE stock, worth $3.78 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

20,453

Previous 17,860 14.52%

Holding current value

$3.78 Million

Previous $2.55 Million 80.18%

% of portfolio

0.02%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$143.93 - $224.51 $373,210 - $582,154	2,593 Added 14.52%	20,453 $4.59 Million
Q2 2023 Jul 31, 2023	BUY	$178.3 - $266.78 $245,519 - $367,356	1,377 Added 8.35%	17,860 $3.18 Million
Q4 2022 Feb 06, 2023	SELL	$125.51 - $229.3 $1.38 Million - $2.52 Million	-10,972 Reduced 39.96%	16,483 $3.63 Million
Q3 2022 Nov 04, 2022	BUY	$131.8 - $202.24 $215,493 - $330,662	1,635 Added 6.33%	27,455 $3.7 Million
Q2 2022 Jul 29, 2022	SELL	$121.11 - $216.05 $15,744 - $28,086	-130 Reduced 0.5%	25,820 $4.18 Million
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $145,787 - $268,212	995 Added 3.99%	25,950 $4.89 Million
Q4 2021 Feb 09, 2022	SELL	$248.56 - $389.34 $600,023 - $939,866	-2,414 Reduced 8.82%	24,955 $6.51 Million
Q3 2021 Nov 02, 2021	BUY	$249.6 - $403.14 $96,345 - $155,612	386 Added 1.43%	27,369 $9.93 Million
Q2 2021 Aug 03, 2021	SELL	$292.75 - $367.01 $365,352 - $458,028	-1,248 Reduced 4.42%	26,983 $9.26 Million
Q1 2021 May 14, 2021	SELL	$260.64 - $382.12 $186,878 - $273,980	-717 Reduced 2.48%	28,231 $9.83 Million
Q4 2020 Feb 12, 2021	SELL	$221.31 - $316.61 $53,778 - $76,936	-243 Reduced 0.83%	28,948 $7.09 Million
Q3 2020 Nov 13, 2020	BUY	$189.18 - $286.44 $14,756 - $22,342	78 Added 0.27%	29,191 $8.36 Million
Q2 2020 Aug 14, 2020	BUY	$123.9 - $195.41 $281,376 - $443,776	2,271 Added 8.46%	29,113 $5.49 Million
Q1 2020 May 14, 2020	BUY	$121.84 - $173.19 $41,425 - $58,884	340 Added 1.28%	26,842 $3.3 Million
Q4 2019 Feb 14, 2020	BUY	$115.78 - $208.34 $95,055 - $171,047	821 Added 3.2%	26,502 $4.39 Million
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $33,408 - $41,076	277 Added 1.09%	25,681 $3.15 Million
Q2 2019 Aug 14, 2019	BUY	$113.99 - $146.86 $235,959 - $304,000	2,070 Added 8.87%	25,404 $3.15 Million
Q1 2019 May 15, 2019	SELL	$122.82 - $151.83 $3.61 Million - $4.47 Million	-29,432 Reduced 55.78%	23,334 $3.08 Million
Q4 2018 Feb 13, 2019	BUY	$107.01 - $175.15 $5.65 Million - $9.24 Million	52,766 New	52,766 $7.4 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.2B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.

Account

Asset Management One Co., Ltd. Bei Gene, Ltd. Transaction History